Xtant Medical to Issue Third Quarter 2019 Financial Results on November 7, 2019
05 November 2019 - 8:05AM
Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global
medical technology company focused on surgical solutions for the
treatment of spinal disorders, today announced that it will release
its financial results for the third quarter ended September 30,
2019, before the open of the financial markets on Thursday,
November 7, 2019.
Sean Browne, President and Chief Executive Officer, and Greg
Jensen, Vice President, Finance and Chief Financial Officer, will
host a conference call on Thursday, November 7 at 9:00 AM ET to
review results.
Conference
DetailsConference Date: Thursday,
November 7, 2019 - 9:00 AM ETConference dial-in:
877-407-6184International dial-in:
201-389-0877Conference Call Name: Xtant Medical
Third Quarter 2019 Results CallWebcast
Registration: Click Here
Following the live call, a replay will be
available on the Company’s website, www.xtantmedical.com, under
“Investor Info.”
About Xtant Medical Holdings,
Inc.Xtant Medical Holdings, Inc. (www.xtantmedical.com) is
a global medical technology company focused on the design,
development, and commercialization of a comprehensive portfolio of
orthobiologics and spinal implant systems to facilitate spinal
fusion in complex spine, deformity and degenerative procedures.
Xtant people are dedicated and talented, operating with the highest
integrity to serve our customers.
Investor Relations Contact
David CareyLazar FINN Partners Ph: 212-687-1768Email:
david.carey@finnpartners.com
Xtant Medical (AMEX:XTNT)
Historical Stock Chart
From Apr 2024 to May 2024
Xtant Medical (AMEX:XTNT)
Historical Stock Chart
From May 2023 to May 2024